Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRBP |
---|---|---|
09:32 ET | 1067 | 48.55 |
09:34 ET | 1683 | 48.415 |
09:38 ET | 100 | 48.83 |
09:39 ET | 100 | 48.83 |
09:41 ET | 2300 | 48.615 |
09:43 ET | 100 | 48.98 |
09:45 ET | 796 | 49.31 |
09:48 ET | 2059 | 49.545 |
09:50 ET | 300 | 49.5087 |
09:52 ET | 300 | 49.565 |
09:54 ET | 1000 | 49.525 |
09:56 ET | 22304 | 50.23 |
09:57 ET | 5240 | 49.82 |
09:59 ET | 1614 | 49.82 |
10:01 ET | 8769 | 49.82 |
10:03 ET | 100 | 49.74 |
10:06 ET | 500 | 49.825 |
10:08 ET | 200 | 49.82 |
10:10 ET | 200 | 49.6675 |
10:12 ET | 1800 | 50 |
10:14 ET | 3578 | 49.96 |
10:15 ET | 1283 | 50.145 |
10:17 ET | 1900 | 49.62 |
10:19 ET | 409 | 49.8764 |
10:21 ET | 5155 | 49.11 |
10:28 ET | 3100 | 48.3 |
10:30 ET | 1906 | 48.31 |
10:33 ET | 100 | 49.48 |
10:35 ET | 8118 | 48.33 |
10:37 ET | 5426 | 48.0756 |
10:39 ET | 1239 | 47.72 |
10:42 ET | 229 | 47.73 |
10:44 ET | 1400 | 47.65 |
10:48 ET | 1053 | 47.1 |
10:50 ET | 1216 | 47.2724 |
10:51 ET | 250 | 47.065 |
10:53 ET | 400 | 47.065 |
10:55 ET | 600 | 47.07 |
10:57 ET | 200 | 47.3449 |
11:02 ET | 600 | 47.0101 |
11:04 ET | 200 | 47.62 |
11:08 ET | 300 | 47.7279 |
11:09 ET | 100 | 47.66 |
11:11 ET | 100 | 47.545 |
11:13 ET | 323 | 47.555 |
11:22 ET | 100 | 47.56 |
11:27 ET | 100 | 47.66 |
11:29 ET | 100 | 47.745 |
11:31 ET | 2500 | 47.65 |
11:33 ET | 1097 | 47.37 |
11:38 ET | 7796 | 46.27 |
11:40 ET | 325 | 46.25 |
11:42 ET | 860 | 46.2 |
11:44 ET | 300 | 46.01 |
11:45 ET | 950 | 46.225 |
11:47 ET | 300 | 46.04 |
11:49 ET | 1154 | 46.47 |
11:51 ET | 100 | 46.22 |
11:54 ET | 717 | 46.19 |
11:56 ET | 200 | 46.15 |
11:58 ET | 100 | 46.3943 |
12:00 ET | 150 | 46.3622 |
12:02 ET | 100 | 46.55 |
12:03 ET | 100 | 46.705 |
12:05 ET | 100 | 46.55 |
12:07 ET | 300 | 46.54 |
12:14 ET | 2500 | 46.54 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Corbus Pharmaceuticals Holdings Inc | 518.8M | -6.7x | --- |
Celcuity Inc | 524.7M | -6.0x | --- |
Astria Therapeutics Inc | 526.6M | -4.0x | --- |
Korro Bio Inc | 506.3M | -1.2x | --- |
Olema Pharmaceuticals Inc | 532.5M | -4.6x | --- |
Erasca Inc | 533.1M | -2.7x | --- |
Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $518.8M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 10.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.56 |
EPS | $-6.97 |
Book Value | $-1.56 |
P/E Ratio | -6.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.